Close Menu

NEW YORK — The US Food and Drug Administration this week granted separate Emergency Use Authorizations for PCR-based SARS-CoV-2 tests from Centogene, Aeon Global Health, Akron Children's Hospital, and National Jewish Health.

Centogene's CentoSure-SARS-CoV-2 RT-PCR Assay is designed to detect two regions of the virus' N gene in dry oropharyngeal swab specimens. It runs in a multiplex format that detects all of its targets with different fluorophores.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.